RankAlpha logo
Back to Rankings

EPRX

EupraxiaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
EPRX vs peer average
26/100
EPRX vs. peer average (D vs. B)
Grade spread
A 2 · B 4 · C 1 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

OCGN is the first available peer comparator.

Loose same-sector market-cap proxy from the packet; no direct clinical or indication comparability was established.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerOCGNOcugen
EPRX
Eupraxia
OCGN
Ocugen
Grade
D
A
Momentum
70
92
Value
41
41
Sentiment
39
86
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs OCGN

EPRX / OCGN
Grade Position
Below peers
EPRX vs. peer average (D vs. B)
26/100
Momentum
70
OCGN
Value
41
EPRX
Sentiment
39
OCGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EPRX
1
OCGN
OCGN
A
100/100
-3
2
OVID
OVID
D
40/100
Even
3
PRTA
PRTA
B
80/100
-2
4
PBYI
Puma Biotechnology Inc Common
B
80/100
-2
5
RZLT
Rezolute Inc Common
D
40/100
Even
OCGN is the first peer returned for this comparison set.